Table 2.
Summary of the published literature on patients with Mycobacterium franklinii (N = 33).
| Ref | Journal | No pts | Diagnostic tool | Clinical presentation | Antibiotic used |
|---|---|---|---|---|---|
| [7] | International Journal of Dermatology | 1 | RNA Polymerase B gene sequencing | Skin rash associated with Tattoos | Clarithromycin and Doxycycline |
| [3] | Clinical Research in Dermatology | 1 | RNA Polymerase B gene sequencing | Skin rash associated with Tattoos | Clarithromycin and Doxycycline |
| [1] | Emerging infectious Diseases | 26 | Sequencing: ITS region (between 16 S and 23 S rRNA genes), hsp65, rpoB, and sodA genes complete 16 S rRNA gene sequence analysis in conjunction with cefoxitin and minocycline susceptibility patterns. |
20: patients with lower respiratory tract diseaseABC 2: patients with skin infection 1: patient with granulomatous liver lesionD 2: patients with central line infection and sinusitisE |
A Cefepime B Fluoroquinolones c Azithromycin, ethambutol and rifampin D Clindamycin, ceftazidime ELevofloxacin, cefoxitin, clarithromycin |
| [4] | Genes | 5 | By the following: SAMSA2 and Kraken2, SAMSA2 and 16 S rRNA sequencing, or the by Kraken2 and 16 S rRNA |
Lung cancer | Not reported |